ArticleVirchows Archiv : an international journal of pathology2026
Evidence for non-mucinous pulmonary lesions with adenocarcinoma in situ morphology exceeding the current 3 cm WHO threshold.
Article in Virchows Archiv : an international journal of pathology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
contextThe World Health Organization (WHO) recognizes adenocarcinoma in situ (AIS) of the lung for tumors up to 3 cm in size. Larger tumors with a lepidic growth pattern are classified as invasive lepidic predominant adenocarcinoma.
objectiveThe aim of this study was to demonstrate that pulmonary non-mucinous lesions with adenocarcinomas in situ morphology, but larger than 3 cm and even larger than 7 cm exist. MATERIAL AND
methodsFrom two patients with an extensive pneumonia-like pattern on radiological imaging, complete histological embedding of the affected lobe was performed. In addition, from a nationwide retrospective pT3N0M0 cohort a subset of 112 adenocarcinoma patients, characterized by tumors exceeding 7 cm in diameter, was subjected to further analysis. Follow-up data for potential non-invasive cases were collected, their radiological findings reviewed, and comparisons made with matched controls.
resultsIn two patients the entire lobe was examined, with 130 and 312 tissue blocks, respectively. The histological diagnosis was lepidic growth, without any signs of invasion, as seen in AIS. Both cases had a pT size of 16 cm. In a subset of the T3N0 cohort, 3 out of 112 cases were retrospectively identified as purely non-invasive lepidic proliferations. Radiological imaging revealed consolidation and ground-glass pattern, like that observed in pneumonia and follow-up showed a recurrence-free survival.
conclusionsPulmonary non-mucinous proliferation with adenocarcinoma in situ morphology may become much larger than the 3 cm WHO threshold for AIS and may present with a pneumonia type pattern on CT imaging. The restriction of the 3 cm size criterion for AIS may therefore be reconsidered. A serious consequence for the pathology practice is that the whole lesion of such cases needs to be sampled, to exclude invasion.
Indexed as
Identifiers
42566046What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.